Glycobiology: Global Markets for Diagnostics and Therapeutics

Report Code: BIO153B

Publish Date: Apr 2023

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

Single User License: $5500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global glycobiology market should reach $5.3 billion by 2027 from $3.2 billion in 2022 at a compound annual growth rate (CAGR) of 11.1% for the forecast period of 2022 to 2027.

Report Includes

  • 51 tables
  • An up-to-date overview and analysis of the global markets for glycobiology diagnostics and therapeutics
  • Analyses of the global market trends, with historic revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the market potential for glycobiology market, industry growth drivers, and areas of focus to forecast this market into various segments and subsegments
  • Estimation of the actual market size and revenue forecast for global glycobiology market in USD million terms, and corresponding market share analysis by major market segments and region
  • A look at new tools for synthesizing, modifying and studying oligosaccharides and glycoconjugates
  • Evaluation of promising candidates for carbohydrate-based diagnostics, drugs and vaccines
  • Insight into how glycobiology offers enormous untapped potential in the discovery of new therapeutics derived from saccharides or other molecules which target the biosynthesis and function of saccharides
  • Identification of leading biotechnology companies poised to introduce products during the forecast period, and their impact on the face of the competitive environment
  • Insight into recent industry structure for glycobiology diagnostics and therapeutics, current competitive scenario, clinical trials, ongoing research (R&D) activities, strategic alliances, and COVID-19 impact on the progress of this market
  • Profile descriptions of the major market players, including Agilent Technologies Inc., Bio-Techne, Merck KGaA, Takara Bio Inc. and Waters Corp.

Report Scope

The current report will provide an in-depth look at the glycobiology market. This report analyzes glycobiology market trends with data from 2021, estimates for 2022, projections of compound annual growth rates through 2027 (forecast period of 2022 to 2027), and regional market data. This report will highlight the current and future market potential of glycobiology along with providing a detailed analysis of the competitive environment. Regulatory scenarios, drivers, restraints, and opportunities will be covered in the current report. The report also covers market projections for 2027 and indicates the market share for key market players.

The scope of the market in this report is segmented into glycobiology segment and region. The segments of glycobiology are: glycobiology therapeutics, glycobiology diagnostics, and glycobiology reagents and tools. The regional markets are North America, Europe, Asia-Pacific, and other world regions (Rest of the World). Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Japan, China, and India will be covered within their respective regional segments. For market estimates, data will be provided for 2021 as the base year, with forecasts for 2022 and 2027.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022 to 2027
Base year market size $3.2 billion
Market size forecast $5.3 billion
Growth rate CAGR of 11.1% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered Segment and region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (ROW)
Countries covered U.S., Canada, Germany, France, U.K, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Rest of Asia-Pacific
Key Market Drivers
  • Technological Advancements in the Analysis of Glycans
  • Rising Prevalence of Chronic Disorders Globally
  • Increasing R&D Investment by Pharma Companies
  • Challenges in Glycobiology
  • Inorganic Strategies among Market Players
Companies studied
AGILENT TECHNOLOGIES INC.AMSBIO LLC.
BIO-TECHNEISOSEP
LUDGER LTD.MERCK KGAA
NEW ENGLAND BIOLABSTAKARA BIO INC.
THERMO FISHER SCIENTIFIC INC.WATERS CORP.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

• The global market for glycobiology is estimated at $3.2 billion in 2022 and is expected to grow at a CAGR of 11.1% to $5.3 billion by 2027.
• The key factors driving the growth of glycobiology market include technological advancements in the analysis of glycans, the rising prevalence of chronic disorders globally, increasing R&D investment by pharma companies and many others.
• The catheters market is segmented based on application and region.
• Glycobiology Therapeutics segment will dominate the market by the end of 2027.
• North America holds the highest share in the market.
• Key companies in the market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Techne, Merck KGaA, Takara Bio Inc. and others.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Glycobiology: Global Markets for Diagnostics and Therapeutics123Free
Chapter- 1: Introduction6Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market Dynamics11Free
Chapter- 4: Market Overview23Free
Chapter- 5: Impact of COVID-19 on Market2Free
Chapter- 6: Glycobiology Therapeutics Market11Free
Chapter- 7: Glycobiology Diagnostics Market 15Free
Chapter- 8: Glycobiology Reagents and Tools Market 11Free
Chapter- 9: Market Breakdown by Region11Free
Chapter- 10: Analysis of Market Opportunities2Free
Chapter- 11: Competitive Landscape1Free
Chapter- 12: Company Profiles26Free
Chapter- 13: Appendix: Acronyms1Free
Published - Sep-2016| Analyst - Marianna Tcherpakov| Code - BIO153A

Report Highlights

The global market for glycobiology will grow from nearly $24.6 billion in 2016 to nearly $50.1 billion by 2021 with a compound annual growth rate (CAGR) of 15.3% for the period of 2016-2021.

Report Includes

  • An overview of the global markets for glycobiology diagnostics and therapeutics.
  • Analyses of market trends, with data from 2015, 2016, and projections of CAGRs through 2021.
  • Analyses of current trends, products, evolving technologies and new glycobiology related platforms in different clinical areas including oncology, immunology, cardiovascular, infectious diseases and neurodegeneration.
  • A look at new tools for synthesizing, modifying and studying oligosaccharides and glycoconjugates.
  • Evaluation of promising candidates for carbohydrate-based diagnostics, drugs and vaccines.
  • Insight into how glycobiology offers enormous untapped potential in the discovery of new therapeutics derived from saccharides or other molecules which target the biosynthesis and function of saccharides.
  • Profiles of major players in the industry.

Related Reports

Commercial Amino Acids

Published - Jul 2023 | Publisher - BCC Publishing | Code - BIO007M

The global amino acids market was $28.6 billion in 2022 and it should reach $38.8 billion by 2028 from $30.1 billion in 2023 at a compound annual growth rate (CAGR) of 5.2% for the forecast period of 2023 to 2028.

Metabolomics: Technologies and Global Markets

Published - Dec 2021 | Publisher - BCC Publishing | Code - BIO055D

The global metabolomics market should reach $22.7 billion by 2026 from $12.7 billion in 2021 at a compound annual growth rate (CAGR) of 12.3% for the forecast period of 2021 to 2026.

Global DNA Sequencing: Research, Applied and Clinical Markets

Published - Aug 2021 | Publisher - BCC Publishing | Code - BIO045H

The global market for DNA Sequencing should grow from $15.7 billion in 2021 to $37.7 billion by 2026, at compound annual growth rate (CAGR) of 19.1% for the period of 2021-2026.

Drug Discovery Technologies

Published - Apr 2021 | Publisher - BCC Publishing | Code - BIO020G

The global market for drug discovery technologies should grow from $69.8 billion in 2020 to $110.4 billion by 2025 with a compound annual growth rate (CAGR) of 9.6% for the period of 2020-2025.

Recent Reports

Global Recombinant Proteins Market

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO254A

The global market for recombinant proteins is estimated to increase from $132.4 billion in 2023 to reach $203.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.5% from 2024 through 2029.

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics

Published - Jun 2024 | Publisher - Gundreddy Gopinadh | Code - BIO157C

The global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Medical Robotics and Computer-assisted Surgery: The Global Market

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC036J

The global market for medical robotics and computer-assisted surgery is expected to grow from $11.5 billion in 2023 and projected to reach $19.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Sensors: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - IAS006P

The global market for sensors is estimated to increase from $179.7 billion in 2023 to reach $300.5 billion by 2029, at a compound annual growth rate (CAGR) of 8.9% from 2024 through 2029.

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Water Filtration: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - MST080B

The global market for water filtration is expected to grow from $10.5 billion in 2024 and is projected to reach $19.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.5% during the forecast period of 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Glycobiology: Global Markets for Diagnostics and Therapeutics
Sample Report